FibroBiologics Inc. Commo...

1.22
0.07 (6.55%)
At close: Mar 04, 2025, 12:07 PM

FibroBiologics Common Stock Balance Sheet Statement

Year FY23 FY22 FY21 FY20
Cash & Equivalents 9.16M 2.27M 407K n/a
Short-Term Investments n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a
Other Long-Term Assets n/a n/a n/a n/a
Receivables n/a 300K n/a n/a
Inventory n/a n/a n/a n/a
Other Current Assets 52K 59K 61K n/a
Total Current Assets 9.21M 2.63M 468K n/a
Property-Plant & Equipment 2.61M 2.2M n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a
Total Long-Term Assets 2.61M 2.2M n/a n/a
Total Assets 11.82M 4.82M 468K n/a
Account Payables 1.38M 493K 233K n/a
Deferred Revenue n/a n/a n/a n/a
Short-Term Debt 362K 5.78M 1.52M n/a
Other Current Liabilities 7.44M 803K n/a n/a
Total Current Liabilities 9.18M 7.07M 1.76M n/a
Long-Term Debt 1.39M 1.75M n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a
Total Long-Term Liabilities 1.39M 1.75M n/a n/a
Total Liabilities 10.57M 8.82M 1.76M n/a
Total Debt 1.75M 7.52M 1.52M n/a
Common Stock 1K 1K n/a 1.17M
Retained Earnings -24.36M -7.87M -2.75M -1.17M
Comprehensive Income n/a 1.46M 1.46M n/a
Shareholders Equity 1.25M -4M -1.29M n/a
Total Investments n/a n/a n/a n/a